- Home
- KRNY vs MDXG Comparison
KRNY vs MDXG Comparison
Compare KRNY & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KRNY | MDXG |
|---|---|---|
| Founded | 1884 | 2006 |
| Country | United States | United States |
| Employees | 549 | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 581.2M | 625.6M |
| IPO Year | 2014 | 2007 |
Fundamental Metrics
Financial Performance| Metric | KRNY | MDXG |
|---|---|---|
| Price | $9.18 | $4.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $10.67 | $7.40 |
| AVG Volume (30 Days) | 401.0K | ★ 899.5K |
| Earning Date | 10-22-2026 | 10-28-2026 |
| Dividend Yield | ★ 4.80% | N/A |
| EPS Growth | ★ 35.71 | 14.29 |
| EPS | ★ 0.57 | N/A |
| Revenue | $2,580,000.00 | ★ $418,630,000.00 |
| Revenue This Year | $11.95 | N/A |
| Revenue Next Year | $11.09 | $21.78 |
| P/E Ratio | $16.04 | ★ N/A |
| Revenue Growth | ★ 36.00 | 19.99 |
| 52 Week Low | $6.23 | $3.03 |
| 52 Week High | $10.24 | $7.97 |
Technical Indicators
Market Signals| Indicator | KRNY | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 32.03 | 54.58 |
| Support Level | $9.05 | $4.11 |
| Resistance Level | $9.74 | $4.76 |
| Average True Range (ATR) | 0.19 | 0.16 |
| MACD | -0.07 | -0.02 |
| Stochastic Oscillator | 9.95 | 47.46 |
Price Performance
Historical ComparisonAbout KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income from their clients.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.